Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
71.27 USD | +3.83% | -2.52% | -0.21% |
Feb. 27 | Ligand Pharmaceuticals' Q4 Adjusted Earnings Rise, Revenue Falls; Reaffirms 2024 Guidance | MT |
Feb. 27 | Transcript : Ligand Pharmaceuticals Incorporated, Q4 2023 Earnings Call, Feb 27, 2024 |
- Stock
- Equities
- Stock Ligand Pharmaceuticals Incorporated - Nasdaq
- News Ligand Pharmaceuticals Incorporated